Diametrics re-emerges with glucose monitoring focus
This article was originally published in Clinica
St Paul, Minnesota based Diametrics Medical says it has secured $3m in financing and will reorganise its business to develop new products to continuously monitor and control glucose in critically ill patients. The company laid off most of its workers in October after struggling for some time to breathe life into its TrendCare fibre-optic continuous blood gas monitoring products. That business has now been discontinued.